The Jumonji-domain histone demethylase inhibitor JIB-04 deregulates oncogenic programs and increases DNA damage in Ewing Sarcoma, resulting in impaired cell proliferation and survival, and reduced tumor growth
Janet K. Parrish(University of Colorado Denver), Paul Jedlicka(University of Colorado Denver)
Cited by 53